Back

Kiadis Pharma N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 08 jul 2020 - 07:00
  • Statutory name Kiadis Pharma N.V.
  • Title Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties

Related downloads

202007080000000001_Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties.pdf

Date last update: 10 August 2022

Share information

Share on: Share this